Recent Advances in Biosensors for Pharmaceutical Analysis
A special issue of Biosensors (ISSN 2079-6374). This special issue belongs to the section "Nano- and Micro-Technologies in Biosensors".
Deadline for manuscript submissions: 31 December 2026 | Viewed by 3688
Special Issue Editors
Interests: biosensors; electronics engineering; microfluidics; medical engineering; chinese materia medica analysis
Special Issues, Collections and Topics in MDPI journals
Interests: biosensors; HEMT biosensors for natural active compound discovery; herbal analysis; novel drug development
Special Issue Information
Dear Colleagues,
The rapid development of biosensors has made them a critical tool in pharmaceutical research, drug development, and clinical diagnostics. Their core feature lies in integrating biological recognition elements, such as enzymes, antibodies or DNA, with physical or chemical sensors to achieve real-time, highly sensitive detection of drug molecules and their biological effects. In recent years, advancements in nanotechnology, microelectronics and bioengineering have significantly enhanced the sensitivity, specificity and stability of biosensors, enabling their important role in drug screening, drug quality assessment, drug delivery, pharmacokinetics and toxicological studies. For example, electrochemical biosensors can detect the interaction between drugs and target molecules (such as enzymes, receptors and antibodies) in real time to achieve rapid drug screening. By combining organ chips with biosensors, we can analyze the metabolic pathways and toxicity of drugs in a simulated environment, reducing the use of animal experiments. Implantable biosensors can directly monitor the drug concentration in patients and adjust the drug release according to real-time data to ensure the accuracy of drug release, so as to improve the curative effect and reduce side effects. In the quality control of the drug production process, biosensors can monitor the drug composition, pollutant content and drug concentration in real time, ensuring that the produced drugs meet the quality standards. With ongoing advancements in nanotechnology, bioengineering and information technology, biosensors are expected to see broader application and adoption in the future, playing a more significant role, especially in drug development, clinical applications and personalized medicine.
This Special Issue, entitled "Recent Advances in Biosensors for Pharmaceutical Analysis”, will collect reviews or original research papers on biosensors for pharmaceutical analysis.
Dr. Wuzhen Qi
Dr. Zhixin Wang
Dr. Xiuli Zhang
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biosensors is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biosensors
- microfluidics
- organ-on-chip
- drug screening
- drug quality assessment
- drug delivery
- pharmacokinetics
- toxicological studies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
